Thyroid blood tests: TSH, free T4, free T3 and TPO antibodies

“Thyroid panel” is a convenient label, not one universal set of tests. A laboratory may sell TSH alone, TSH with free T4 (FT4), or a larger package containing free T3 (FT3) and thyroid antibodies. More tests are not automatically more accurate. The useful combination depends on the clinical question, medicines, pregnancy status and whether pituitary disease is plausible.

For most adults with suspected primary thyroid dysfunction, professional guidance supports a TSH-first cascade. The laboratory can measure additional hormones from the same sample only when TSH is outside its reference interval. This article explains that sequence and its limits; it cannot diagnose the cause of symptoms or tell you to start, stop or change treatment.

The TSH-first cascade

TSH is produced by the pituitary and responds to circulating thyroid hormone through a feedback loop. In an adult without suspected pituitary disease, NICE recommends starting with TSH:

TSH within range: additional thyroid hormones are often unnecessary for initial screening.
TSH above range: measure FT4 in the same sample.
TSH below range: measure FT4 and FT3 in the same sample.

This is “cascading” or “reflex” testing. It reduces unhelpful measurements while preserving the tests needed to characterise common primary hypothyroid and thyrotoxic patterns. It is not a rule for every person. Children and young people, pregnancy, suspected pituitary or hypothalamic disease, severe acute illness and some treatment-monitoring situations require a different approach chosen by a clinician.

Our detailed TSH guide explains the feedback signal and laboratory reference intervals. The key point here is that TSH is a starting signal, not a diagnosis by itself.

What FT4 and FT3 add

FT4 estimates the unbound fraction of thyroxine available to tissues. When TSH is raised, FT4 helps distinguish a pattern with thyroid hormone still within range from one with low circulating hormone. When TSH is low, FT4 shows whether thyroxine is elevated.

FT3 is most useful when TSH is suppressed and hyperthyroidism or thyrotoxicosis is being assessed. T3 may rise before T4 in some cases. FT3 is not routinely needed to look for hypothyroidism: a person can have significant primary hypothyroidism with a normal T3 result, and isolated low T3 is common in non-thyroidal illness. Free T3 assays can also be less robust than TSH and FT4 assays.

“Free” and “total” hormone results are not interchangeable. Changes in binding proteins—particularly during pregnancy or oestrogen use—can alter total T4 and T3. Always read the exact test name, units and method-specific interval printed on the report.

Common TSH and FT4 patterns

This table is a map for discussion, not a diagnostic calculator. Results must be checked against the laboratory interval, symptoms, previous values, medicines and clinical context.

TSH pattern	FT4 pattern	What clinicians may consider	Why the pattern is not enough alone
High	Low	Usually primary hypothyroidism; pituitary disease can occasionally produce only mildly high TSH	Cause, persistence, illness, medicines and assay effects still matter
High	Within range	Possible subclinical primary hypothyroid pattern	A repeat result and clinical context may change the interpretation
Low	High	Thyrotoxicosis pattern	FT3, medicines and tests for the cause may be needed
Low	Within range	Possible subclinical hyperthyroid pattern, early change or treatment effect	FT3 and repeat testing may clarify the picture
Low, within range or only mildly high	Low	Possible central hypothyroidism, severe illness or interference	A TSH within range does not reassure when pituitary signalling may be impaired

A discordant or surprising combination should prompt review rather than self-treatment. Laboratories can repeat a measurement, use another assay or investigate interference when the biochemical pattern does not fit the person’s condition.

TPO antibodies explain context, not current function

Thyroid peroxidase antibodies (TPOAb or anti-TPO) can support an autoimmune cause when TSH is raised. They do not show how much hormone the gland is producing today. TSH and FT4 provide that functional information.

NICE advises considering TPO antibodies in adults with TSH above range and advises not repeating the test routinely. Once autoimmune context is established, a rising or falling antibody number generally does not guide levothyroxine dosing or show whether treatment is working. A positive TPO result with normal thyroid function does not, by itself, diagnose hypothyroidism or justify thyroid hormone treatment. Read more in our TPO antibody guide.

Other antibodies answer different questions. For example, TSH-receptor antibodies may help a clinician investigate Graves’ disease. They are not interchangeable with TPO antibodies and are not a default add-on for everyone.

When thyroid blood tests are useful

Testing may be appropriate when symptoms and examination raise suspicion, when a person has another autoimmune condition or new atrial fibrillation, or when a clinician is monitoring known thyroid disease or treatment. Fatigue, weight change, anxiety, low mood, palpitations and temperature intolerance are common and have many possible causes; one symptom alone does not identify thyroid disease.

Avoid treating a commercial “full panel” as a preventive score. A clinician selects tests according to the question. If a test is taken during an unrelated acute illness, temporary non-thyroidal changes can make it harder to interpret. NICE advises against testing during acute illness unless thyroid dysfunction itself is suspected.

Biotin and other reasons results may mislead

High-dose biotin in hair, skin and nail products or other supplements can interfere with some immunoassays. Depending on the platform, results may appear falsely high or falsely low and can mimic a thyroid disorder. Tell the clinician and laboratory the product, dose and last dose taken. The American Thyroid Association advises avoiding biotin for at least two days before thyroid testing, but the appropriate pause can depend on dose, assay and clinical urgency—follow the laboratory or clinician’s instructions rather than delaying urgent care.

Also disclose thyroid medicines, amiodarone, lithium, iodine-containing products, glucocorticoids and other prescriptions or supplements. Do not stop a prescribed medicine solely to “improve” a laboratory result. When monitoring treatment, consistent timing relative to medication and using the same laboratory method can make trends easier to compare.

Pregnancy and pituitary disease are important exceptions

Pregnancy changes thyroid physiology, binding proteins and appropriate reference intervals. Results should be interpreted with pregnancy- and trimester-specific ranges where available. Pregnancy planning, a positive pregnancy test while taking thyroid medication, or an out-of-range result warrants timely contact with the maternity or endocrine team. Do not adjust levothyroxine, antithyroid medicine or iodine on your own.

TSH-first screening also has a crucial pituitary limitation. If there is known pituitary or hypothalamic disease, previous pituitary surgery or radiotherapy, significant head injury, or symptoms suggesting other pituitary hormone problems, clinicians measure TSH and FT4 together. Central hypothyroidism can produce low FT4 with a TSH that is low, normal or only mildly raised—so a TSH inside the printed range can be falsely reassuring.

Diagnosis and monitoring are different jobs

At diagnosis, the goal is to establish a reproducible biochemical pattern and then investigate its cause. Monitoring asks whether a known condition or treatment is stable. The most useful marker can therefore change:

Stable primary hypothyroidism treated with levothyroxine is usually followed mainly with TSH, with FT4 added in selected circumstances.
Early after treatment changes, TSH may lag behind circulating hormone changes; the clinician chooses the interval and markers.
During antithyroid treatment, after radioiodine or surgery, or with central hypothyroidism, TSH alone may be insufficient at particular stages.
TPO antibodies are generally etiologic context, not a repeated response-to-treatment marker.

For therapy that continues for years, it helps to keep the actual intake history in one place — a medication intake log and adherence calendar shows whether the tablet was actually taken each day, not just reported from memory.

Do not change dose, add iodine or take “thyroid support” supplements from one flagged result. The right repeat interval depends on the pattern and urgency; repeating too soon may not show the new steady state.

When to seek prompt or urgent help

Contact the ordering clinician promptly for a new markedly abnormal result, a discordant TSH/FT4 pattern, pregnancy with an out-of-range result, or symptoms that are rapidly worsening. A new or growing neck lump, persistent hoarseness, difficulty swallowing or shortness of breath also needs medical assessment.

Seek urgent medical help for chest pain, severe breathlessness, fainting, a very fast or irregular heartbeat with marked illness, high fever with severe agitation or confusion, seizures, or profound drowsiness and confusion with feeling very cold. Do not wait for a routine repeat blood test when severe symptoms are present.

Tracking thyroid trends with HealthLab

HealthLab can keep reports from different laboratories together and plot TSH, FT4 and FT3 over time. Recording pregnancy, an acute illness, medication timing, supplement use or a laboratory-method change beside a result helps make the trend more useful in a clinical conversation.

Keep antibody results distinct from hormone trends: TPO antibodies describe autoimmune context, while TSH and thyroid hormones show function. HealthLab organises results; it does not diagnose thyroid disease or recommend treatment.

Frequently asked questions

Do I need TSH, FT4, FT3 and TPO antibodies every time?

Usually not. For many adults without suspected pituitary disease, TSH is the first test and FT4 or FT3 is added only when the TSH result indicates it. TPO antibodies may help establish an autoimmune cause when TSH is raised, but routine repeat antibody testing does not guide treatment. Your clinician may order a different combination for pregnancy, children, pituitary disease or treatment monitoring.

Can normal TSH rule out every thyroid problem?

No. It is a strong initial test for common primary thyroid dysfunction, but it can be misleading when pituitary signalling is impaired. Low FT4 with low or inappropriately normal TSH needs clinical assessment. Pregnancy, severe illness, medicines and assay interference can also change how results are interpreted.

Should I stop biotin before a thyroid blood test?

Tell the clinician and laboratory that you take it, including the dose. ATA patient guidance advises avoiding biotin for at least two days before testing, but higher doses and different assays may require tailored instructions. Do not postpone urgent assessment merely to complete a supplement washout.

Does a positive TPO antibody result mean I need treatment?

Not by itself. TPO antibodies can support an autoimmune cause, but treatment decisions depend on thyroid function, symptoms, pregnancy context and other clinical factors. TSH and FT4—not the size of the TPO number—are used to assess current thyroid function.

This material does not replace medical advice. Thyroid blood tests require interpretation in clinical context.